Literature DB >> 27459028

Molecular switch of EZH2 in hypoxia.

Sylvia Mahara1, Wee Joo Chng2, Qiang Yu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27459028      PMCID： PMC5134704          DOI： 10.1080/15384101.2016.1215699

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  A complex Polycomb issue: the two faces of EZH2 in cancer.

Authors:  Hanno Hock
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

2.  Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers.

Authors:  Shuet Theng Lee; Zhimei Li; Zhenlong Wu; Meiyee Aau; Peiyong Guan; R K Murthy Karuturi; Yih Cherng Liou; Qiang Yu
Journal:  Mol Cell       Date:  2011-09-02       Impact factor: 17.970

3.  EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.

Authors:  Michael T McCabe; Heidi M Ott; Gopinath Ganji; Susan Korenchuk; Christine Thompson; Glenn S Van Aller; Yan Liu; Alan P Graves; Anthony Della Pietra; Elsie Diaz; Louis V LaFrance; Mark Mellinger; Celine Duquenne; Xinrong Tian; Ryan G Kruger; Charles F McHugh; Martin Brandt; William H Miller; Dashyant Dhanak; Sharad K Verma; Peter J Tummino; Caretha L Creasy
Journal:  Nature       Date:  2012-10-10       Impact factor: 49.962

4.  HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.

Authors:  Sylvia Mahara; Puay Leng Lee; Min Feng; Vinay Tergaonkar; Wee Joo Chng; Qiang Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-14       Impact factor: 11.205

5.  EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.

Authors:  Chun-Ju Chang; Jer-Yen Yang; Weiya Xia; Chun-Te Chen; Xiaoming Xie; Chi-Hong Chao; Wendy A Woodward; Jung-Mao Hsu; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

6.  NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha.

Authors:  Jordi Rius; Monica Guma; Christian Schachtrup; Katerina Akassoglou; Annelies S Zinkernagel; Victor Nizet; Randall S Johnson; Gabriel G Haddad; Michael Karin
Journal:  Nature       Date:  2008-04-23       Impact factor: 49.962

7.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962
  7 in total
  3 in total

1.  Prolactin Receptor Signaling Regulates a Pregnancy-Specific Transcriptional Program in Mouse Islets.

Authors:  Mark E Pepin; Hayden H Bickerton; Maigen Bethea; Chad S Hunter; Adam R Wende; Ronadip R Banerjee
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 2.  Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.

Authors:  Kaumudi Bhawe; Deodutta Roy
Journal:  Cell Oncol (Dordr)       Date:  2018-07-25       Impact factor: 6.730

3.  Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway.

Authors:  Qi Lv; Kai Wang; Simiao Qiao; Ling Yang; Yirong Xin; Yue Dai; Zhifeng Wei
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.